On Friday, the National Pharmaceutical Pricing Authority (NPPA) fixed the retail prices of 23 formulations, including the medications used to treat diabetes and high blood pressure. The national drug pricing regulator has set the prices of the drugs based on the decision made during the 113th Authority meeting held on May 26, 2023. The prices of these drugs were fixed as per the Drugs (Price Control) Order, 2013.

The NPPA has fixed the price of one tablet of diabetes drugs, namely Gliclazide ER and Metformin Hydrochloride tablets, at Rs 10.03. Similarly, the retail price of one tablet of antihypertensive medications such as telmisartan, chlorthalidone, and cilnidipine tablets has been fixed at Rs 13.17.

The retail price of one tablet of the pain reliever medications Trypsin, Bromelain, Rutoside Trihydrate, and Diclofenac Sodium has been fixed at Rs 20.51. The NPPA has also revised the ceiling price of 15 scheduled formulations under the Drugs (Prices Control) Order, 2013 (NLEM 2022).

They have also fixed the ceiling price for two scheduled formulations. 

(Source:https://www.business-standard.com/industry/news/nppa-fixes-retail-prices-of-23-drug-including-diabetes-blood-pressure-123060900710_1.html )